Diabetic Macular Edema (DME) Treatment with Sustained-Release Corticosteroid Implants (Ozurdex)

When should an Ozurdex intravitreal implant be used instead of anti-VEGF injections? Benefits and duration of efficacy with Dr. Mahmoud Hassan at Mashreq Eye Center.

Ozurdex: Innovative Cortisone Implant for Treating Diabetic Macular Edema

Diabetic Macular Edema (DME) is a serious complication of diabetes that threatens visual acuity. The accumulation of fluid in the macula (the center for precise vision in the retina) leads to blurred vision, difficulty reading, and seeing objects as distorted or wavy. While anti-VEGF injections are often the first line of treatment, there are situations that require other therapeutic options. Here, extended-release cortisone implants like Ozurdex emerge as an effective and sustainable solution. In this article, we will explore when to resort to intravitreal Ozurdex implants instead of anti-VEGF, their advantages, and their duration of efficacy, with Dr. Mahmoud Hassan, a vitreo-retinal surgeon and a key contributor to Al Mashreq Eye Center in Cairo.

When is Ozurdex the Optimal Choice for Diabetic Macular Edema?

In the world of retinal disease treatment, we always strive to provide the most effective and sustainable solutions for patients. For diabetic macular edema, we often start with treatments targeting vascular endothelial growth factor (VEGF), such as Eylea or Vabysmo injections. However, some patients may not respond adequately to these injections, or they may require a large and frequent number of injections to maintain results. In these cases, the Ozurdex implant becomes a highly valuable treatment option.

Scenarios where we might prefer using Ozurdex include:

• Insufficient response to Anti-VEGF injections: When edema does not significantly improve after several injections of conventional medications.
• Need to reduce injection frequency: Ozurdex provides patient comfort by reducing the number of necessary visits and injections, as its efficacy lasts longer.
• Persistent or recurrent edema: In cases of stubborn edema that returns quickly after the effect of conventional injections wears off.
• Certain cases of macular edema associated with retinal vein occlusion: Where corticosteroids may play an effective role in reducing inflammation and edema.
• Patients who experience side effects from Anti-VEGF injections: Although rare, some patients may not tolerate these medications.

How Does the Ozurdex Implant Work?

Ozurdex is a small, bio-degradable implant injected into the vitreous cavity of the eye. This implant contains dexamethasone, a powerful corticosteroid. Once injected, the implant slowly releases dexamethasone over several months, helping to:

• Reduce inflammation: Corticosteroids have strong anti-inflammatory properties, contributing to calming leaky blood vessels in the retina.
• Reduce fluid leakage: It strengthens the blood-retinal barrier and reduces the permeability of blood vessels, thereby limiting fluid accumulation under the retina.
• Improve retinal cell function: Corticosteroids may help protect retinal neural cells from damage caused by chronic edema.

It is worth noting that Ozurdex works differently from Anti-VEGF injections, as it targets different inflammatory pathways, making it an effective complementary or alternative option in certain cases.

Advantages of the Ozurdex Implant and Its Efficacy Period

The Ozurdex implant has several advantages that make it an attractive option in the treatment of diabetic macular edema:

• Long-lasting effect: The implant provides continuous drug release for up to 6 months on average, reducing the need for frequent clinic visits.
• Bio-degradable: The implant gradually degrades inside the eye and does not require surgical removal.
• Proven efficacy: Clinical studies have shown the effectiveness of Ozurdex in improving visual acuity and reducing retinal thickness in many patients with diabetic macular edema.
• Ease of procedure: The implant is injected in the clinic under sterile conditions, and it is a relatively quick procedure.

Scientifically, the duration of drug presence in the eye and its effect may vary from patient to patient based on factors such as the severity of the condition, body response, and the presence of any other influencing factors. Some patients may require repeated injections after the effect of the first implant wears off, and other injections or complementary treatments may be resorted to depending on the case evaluation.

Potential Side Effects of Ozurdex

Like any medical procedure, the Ozurdex implant may be associated with some potential side effects, which should be discussed with the treating physician. The most prominent of these effects include:

• Increased intraocular pressure: This is the most common side effect of corticosteroids and may require regular monitoring and possibly pressure-lowering treatment.
• Increased risk of cataracts: Especially with repeated or prolonged use of corticosteroids.
• Intraocular inflammation or infection: This is a rare yet serious risk, requiring immediate medical attention.
• Vision changes: Some patients may experience temporary blurry vision immediately after the injection.

Dr. Mahmoud Hassan and the team at Al Mashreq Eye Center are keen on carefully evaluating each case and discussing all available treatment options, including the potential risks and benefits of each, to ensure the most appropriate treatment decision for the patient.

Ozurdex vs. Anti-VEGF: A Quick Comparison

The choice between Ozurdex and Anti-VEGF injections depends on several factors, including:

• Mechanism of Action: Ozurdex is a powerful anti-inflammatory (corticosteroid), while Anti-VEGF targets a specific growth factor.
• Duration of Efficacy: Ozurdex lasts longer (up to 6 months) compared to traditional injections (4-8 weeks).
• Side Effects: Ozurdex may increase eye pressure and the risk of cataracts, while Anti-VEGF may cause inflammation or vascular problems (rarely).
• Cost: The approximate price for an Ozurdex implant injection in Egypt in 2026 is around 27,000 EGP. Meanwhile, the approximate price for Eylea / Lucentis injections in Egypt in 2026 is around 9,000 EGP. (Approximate prices and subject to change based on condition).

Ultimately, the goal is to preserve the patient's best possible vision and reduce the risk of vision loss. Sometimes, a combination of different treatments or alternating between them may be required to achieve optimal results.

Conclusion: Ozurdex as a Valuable Tool in the Treatment Arsenal for Diabetic Macular Edema

The Ozurdex implant represents a significant addition to the field of treating diabetic macular edema, especially for patients who have not responded adequately to standard treatments or require a long-term therapeutic option. Thanks to its ability to release cortisone slowly and effectively, Ozurdex offers new hope in preserving visual acuity and improving the quality of life for patients. If you suffer from diabetic macular edema, consulting a specialist a doctor such as Dr. Mahmoud Hassan at Al-Mashreq Eye Center is the first step towards understanding your available treatment options, including the use of Ozurdex implants.

For more information on the latest retinal disease treatment technologies, you can follow Dr. Mahmoud Hassan's YouTube channel: .

For reservations and inquiries: 01002310813

Articles You Might Enjoy Reading

• The Impact of Retinal Surgeries on Future Cataract Development (White Water)
• Phacoemulsification Cataract Surgery: Indian Training and Surgical Expertise for 2026

https://drmahmoud-hassaan.com/en/articles/ozurdex-steroid-implant-diabetic-macular-edema